TEK2day FINANCE Open Terminal →

Varex Imaging Corporation (VREX)

NMS · Healthcare · Medical Devices

$10.29 +1.98%

Closing price as of 2026-06-08 · Source: TEK2day Finance

1-Year Price History +22.2% over period
$15$13$11$9$7 2025-062025-092025-122026-032026-06

Key Metrics

Market Cap
$427.4M
P/S (TTM)
0.5x
Exchange
NMS

About Varex Imaging Corporation

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

Quarterly Financials

Metric2025-06-302025-09-302025-12-312026-03-31
Revenue203.0M228.9M209.6M216.0M
Gross Profit67.5M77.8M69.8M72.6M
Operating Income13.2M19.6M15.4M14.4M
Net Income-89.1M12.2M2.3M-8.1M
Diluted EPS$-2.15$0.29$0.05$-0.19

Annual Financials

Metric2022-09-302023-09-302024-09-302025-09-30
Revenue859.4M893.4M811.0M844.6M
Gross Profit283.5M290.3M256.9M290.5M
Operating Income88.2M77.1M32.1M66.1M
Net Income30.3M47.4M-48.8M-70.3M
Diluted EPS$0.73$1.08$-1.17$-1.70
Want live quotes, estimates, SEC filings, and CEO analytics for VREX?
The free TEK2day terminal runs in your browser — type /VREX to get started.
Open VREX in the Terminal →